2022
Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
Viera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection. Drug And Alcohol Dependence Reports 2022, 3: 100038. PMID: 36845980, PMCID: PMC9948939, DOI: 10.1016/j.dadr.2022.100038.Peer-Reviewed Original Research
2010
Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic
Niccolai LM, Verevochkin SV, Toussova OV, White E, Barbour R, Kozlov AP, Heimer R. Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. European Journal Of Public Health 2010, 21: 613-619. PMID: 20798184, PMCID: PMC3180633, DOI: 10.1093/eurpub/ckq115.Peer-Reviewed Original ResearchConceptsInjection drug usersRetrospective cohort analysisHIV incidenceEnzyme immunoassayHIV epidemicCohort analysisDrug usersBED capture enzyme immunoassayHIV incident casesRecent HIV incidenceHigh HIV incidenceHIV prevention interventionsCross-sectional studyCapture enzyme immunoassayIncident infectionsIncident casesEstimate incidenceIndependent correlatesIncidence rateIncidence estimatesPrevention interventionsCurrent epidemic situationIncidenceVulnerable populationsLow specificity
2009
Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users
Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.Peer-Reviewed Original ResearchRisk reduction materialsSyringe exchange programsInjection drug usersHygiene suppliesDrug usersHealth promotion behaviorsAppropriate useHealth promotion materialsSEP clientsPrevention interventionsHepatitis riskBlood flowInjection practicesPromotion behaviorsInjection siteBrief interventionIntervention effectivenessIntervention packetInterventionPassive introductionPromotion materialsExchange programsOne-quarterSubstantial numberVerbal reminders
2000
Viability of HIV-1 in syringes: implications for interventions among injection drug users.
Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.Peer-Reviewed Original Research